LION

Nanoparticle formulations as components of RNA-based vaccines, namely, RNA drug delivery agents consisting of biologically active compositions in the form of cationic nanoparticles that facilitate the delivery of RNA to biological cells; Nanoparticle formulations as components of RNA-based vaccines, namely, RNA drug delivery agents consisting of cationic nanoparticle emulsions that facilitate the delivery of RNA to biological cells; Drug delivery agents consisting of emulsions that facilitate delivery of RNA-based vaccines, namely delivery of RNA to biological cells for the prevention of infectious diseases